Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypotension or Open Angle Glaucoma

Conditions:   Ocular Hypertension;   Primary Open Angle Glaucoma Interventions:   Drug: Latanoprost ophthalmic solution;   Drug: AKB-9778;   Drug: Placebo Sponsor:   Aerpio Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials